Business Name: |
Akhand Manju MD |
Contact Person: |
Manju Akhand |
Address: |
391 Quadrangle Drive # N2, Bolingbrook, Illinois 60440 |
Phone Number: |
(630) 679-1275 |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Medavaram Meher MD - Bolingbrook, IL 60440 Edward Healthcare Center - Bolingbrook, IL 60440 Malicay Manuel MD - Bolingbrook, IL 60440 Downers Grove Pediatrics Ltd - Bolingbrook, IL 60440 Mohiuddin Ali M MD - Bolingbrook, IL 60440 Rao Jagadish K Padmaja - Bolingbrook, IL 60440 York Ent Surgical Consultants - Bolingbrook, IL 60440 Stephen P Holland - Bolingbrook, IL 60440 Cabana E C MD - Bolingbrook, IL 60440 Pitsilos George MD - Bolingbrook, IL 60440 Gorovits Anatoly MD - Bolingbrook, IL 60440 Sauer Paul MD - Bolingbrook, IL 60440 Holland Steve MD - Bolingbrook, IL 60440 Riginald S Picache Inc - Bolingbrook, IL 60440 Onagan Maria I MD - Bolingbrook, IL 60440 Meyer Karenmarie MD - Bolingbrook, IL 60440 Chittineni Bharati MD - Bolingbrook, IL 60440 Ahmed Irma MD - Bolingbrook, IL 60440 Akl Youssef Emile MD - Bolingbrook, IL 60440 Khan Mohammad M MD - Bolingbrook, IL 60440 |
The company Akhand Manju MD provides B2C services in the form of Doctors from its single location in Illinois.
1 to 4 employees work for Akhand Manju MD, and the business now earns $500.000 to $999.999 per annum.
Akhand Manju MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Akhand Manju MD, please call Manju Akhand with the phone number (630) 679-1275 or visit its single location at 391 Quadrangle Drive # N2 in Bolingbrook, Illinois 60440.
The location of the single location can also be found using the coordinates 41.68891,-88.07539.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.